- Report
- July 2025
- 229 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- July 2025
- 229 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- June 2025
- 209 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- June 2025
- 201 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- June 2025
- 210 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- May 2025
- 221 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- May 2025
- 222 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- May 2025
- 212 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- May 2025
- 213 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- April 2025
- 211 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- March 2025
- 219 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- March 2025
- 206 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- February 2025
- 222 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- February 2025
- 211 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- December 2024
- 201 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- December 2024
- 198 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- December 2024
- 157 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- December 2024
- 172 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- November 2024
- 151 Pages
Global
From €2239EUR$2,500USD£1,948GBP
- Report
- November 2024
- 158 Pages
Global
From €2239EUR$2,500USD£1,948GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more